US Pharm. 2009;34(5):36-38. 

Teva Pharmaceutical Industries Ltd. has begun shipping its generic version of Shire Pharmaceuticals' Adderall XR (mixed salts of a single-entity amphetamine product) Capsules, 5 mg, 10 mg, 20 mg, 25 mg, and 30 mg. Teva's generic Adderall XR Capsules are indicated in the treatment of attention-deficit hyperactivity disorder.  

Teva has also received FDA approval to market a generic version of Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz (drospirenone and ethinyl estradiol) Tablets. As the first company to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for this product, Teva has been awarded a 180-day exclusivity.